Cargando…

MON-465 Novel Thyroid Hormone β Mutation L266s Causes Atrial Fibrillation & Cerebral Infarction

Background: Resistance against thyroid hormone β (RTHβ) is characterized by reduced tissue sensitivity to thyroid hormone. Patients with RTHβ resistance typically demonstrate increases in FT3 and FT4 accompanied by inappropriately elevated TSH. Mutations in the TRβ gene are the most common genetic d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ono, Wataru, Kameda, Hiraku, Iesaka, Hiroshi, Izumihara, Satomi, Oe, Yuki, Kamigaki, Risa, Chiba, Koki, Kameda, Rena, Nomoto, Hiroshi, Cho, Kyu Yong, Nakamura, Akinobu, hayashi, Yoshitaka, Hideaki, Miyoshi, Atsumi, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209217/ http://dx.doi.org/10.1210/jendso/bvaa046.399

Ejemplares similares

MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia
por: Chiba, Koki, et al.
Publicado: (2020)

SAT-271 Block and Replace Therapy Successfully Improved Symptoms in Recurrent Cyclic Cushing’s Disease
por: Kamigaki, Risa, et al.
Publicado: (2020)

SAT-413 Does Dipeptidyl Peptidase-4 Inhibitor Exacerbate Graves’ Disease?
por: Sekizaki, Tomonori, et al.
Publicado: (2020)

Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study
por: Oe, Yuki, et al.
Publicado: (2022)

ODP037 Effects of DHCR24 Inhibitor on Excessive Adrenal Steroidogenesis in db/db mouse
por: Kamigaki, Risa, et al.
Publicado: (2022)

SAT040 Administration Of A DHCR24 Inhibitor Reduces The Excessive Adrenal Steroidogenesis In db/db Mice Through Effects The Alteration Of Intracellular Cholesterol Metabolism
por: Kamigaki, Risa, et al.
Publicado: (2023)

ODP332 Maternal Central Diabetes Insipidus Immediately after Delivery, Owing to Vasospasm of the Internal Carotid Artery
por: Yokozeki, Kei, et al.
Publicado: (2022)

MON-492 A Case of Gitelman’s Syndrome with Hyperphosphatemia That Responded Effectively to Single Oral Administration of Magnesium Oxide
por: Miya, Aika, et al.
Publicado: (2019)

Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment
por: Nomoto, Hiroshi, et al.
Publicado: (2019)

Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study
por: Nomoto, Hiroshi, et al.
Publicado: (2023)

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes
por: Chiba, Koki, et al.
Publicado: (2020)

SAT-282 Hypothalamic Pituitary Adrenal Axis Hyperactivity in Db/db Mice
por: Kameda, Hiraku, et al.
Publicado: (2020)

Favorable Effects of Burosumab on Fibroblast Growth Factor 23-Related Osteomalacia: A Case Report
por: Oe, Yuki, et al.
Publicado: (2021)

SAT-465 Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis: Diagnosis or Distraction?
por: de Souza, Tamara Gizelle, et al.
Publicado: (2020)

SAT465 Spectral Doppler Ultrasound in Thyrotoxicosis, a Valuable Bedside Tool
por: Morkos, Michael, et al.
Publicado: (2023)

Preferable effects of pemafibrate on liver function and fibrosis in subjects with type 2 diabetes complicated with liver damage
por: Nomoto, Hiroshi, et al.
Publicado: (2023)

Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report
por: Oe, Yuki, et al.
Publicado: (2021)

Neuromedin B Receptor Antagonist Suppresses Pomc Expression in AtT-20 Cells and Human Corticotroph Adenoma Cells
por: Sekizaki, Tomonori, et al.
Publicado: (2021)

Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment
por: Miya, Aika, et al.
Publicado: (2020)

ODP338 Neuromedin B Receptor Antagonist Suppresses ACTH Secretion and Cell Proliferation in Human and Mouse Corticotroph Adenoma
por: Atsumi, Tatsuya, et al.
Publicado: (2022)

FRI465 Thyroid Incidentalomas In Hospitalized Patients With COVID-19: A Single-Center Retrospective Analysis
por: Jantarapootirat, Methus, et al.
Publicado: (2023)

The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study
por: Handa, Takahisa, et al.
Publicado: (2021)

ODP285 A Case of Encephalitis and Adrenal Insufficiency in a Patient With Panhypopituitarism After COVID-19 Vaccination
por: Yabe, Ichiro, et al.
Publicado: (2022)

THU044 The Subcellular Localization Of β-Catenin Is Associated With Tumor Size And The Surgical Remission Rate In Growth Hormone-producing Pituitary Adenomas
por: Kuwabara, Saki, et al.
Publicado: (2023)

Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia
por: Oba‐Yamamoto, Chiho, et al.
Publicado: (2020)

Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring
por: Miya, Aika, et al.
Publicado: (2021)

ODP465 BRAF V600 and NRAS Q61 mutations in thyroid fine-needle aspiration (FNA) with indeterminate cytology in Argentina
por: Repetto, Esteban M, et al.
Publicado: (2022)

Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study
por: Sekizaki, Tomonori, et al.
Publicado: (2021)

Gitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report
por: Miya, Aika, et al.
Publicado: (2019)

ODP328 Longitudinal Multidisciplinary Approach for Cabergoline-Resistant Aggressive Prolactinoma Complicated by Multiple Endocrine Neoplasia Type 1
por: Furusawa, Sho, et al.
Publicado: (2022)

MON-552 Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma
por: Akaishi, Junko, et al.
Publicado: (2019)

Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)
por: Nomoto, Hiroshi, et al.
Publicado: (2022)

Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis
por: Miyoshi, Arina, et al.
Publicado: (2020)

MON-613 Lipid Abnormalities In Thyroid Dysfunction.
por: Franco, Luiz Fernando
Publicado: (2019)

MON-611 Biux2x2
por: Kushchayeva, Yevgeniya, et al.
Publicado: (2019)

MON-449 Thyroid Microcarcinoma Histopathology Relevance
por: Sandoval, Letícia A M, et al.
Publicado: (2020)

MON-482 Thyroid Tuberculosis - An Unlikely Diagnosis
por: Araújo, Alexandra Novais, et al.
Publicado: (2020)

MON-470 Biotin Masquerading as Subclinical Hyperthyroidism
por: Eapen, Anita, et al.
Publicado: (2020)

Acromegaly Cases Exhibiting Increased Growth Hormone Levels during Oral Glucose Loading with Preadministration of Dipeptidyl Peptidase-4 Inhibitor
por: Oba-Yamamoto, Chiho, et al.
Publicado: (2021)

MON-615 Seasonal Changes in Thyroid Function in Healthy Subjects in Japan: Analysis of 8,489 Health Check Participants
por: Yamada, Sayaka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_32oj3fdbnii17tum0e7lcldj8s